(Press-News.org) UCLA researchers have provided the first evidence that a simple blood test could be developed to confirm the presence of beta amyloid proteins in the brain, which is a hallmark of Alzheimer's disease.
Although approximately 5 million Americans are living with Alzheimer's, no reliable blood-based test currently exists for the neurodegenerative disorder that is the sixth-leading cause of death in the United States. Using blood-based biomarkers -- a signature of proteins in the blood that indicate the presence of a disease -- to diagnose Alzheimer's could be a key advance.
"Blood-based biomarkers would have the important advantage of being safe, affordable and easy to administer in large groups or in rural areas, and therefore could have an enormous impact on clinical care and clinical trials alike," said Dr. Liana G. Apostolova, director of the neuroimaging laboratory at the Mary S. Easton Center for Alzheimer's Disease Research at UCLA and head of the research team. Results of the study appeared in the journal Neurology.
Alzheimer's disease can be diagnosed definitively only by examining brain tissue after death. While people are alive, physicians must rely on proxy measures, or biomarkers, along with cognitive symptoms such as memory loss.
Two current methods for determining the beta-amyloid formation characteristic of Alzheimer's disease both have drawbacks. Cerebrospinal fluid can be obtained from patients, but that requires a spinal tap, an invasive procedure that carries the risk of nerve damage and other serious side effects. Another method, the amyloid PET scan, while effective, exposes subjects to radiation. The PET scan is also expensive and is not typically covered by insurance as a diagnostic test. Also, few medical centers have the technology.
For their study, the UCLA researchers developed a simple signature for predicting the presence of brain amyloidosis -- the build-up of amyloid in the brain -- including several blood proteins known to be associated with Alzheimer's disease, along with information routinely obtained in the course of a clinical work-up for patients suspected to have the disease, such as results of memory testing and structural magnetic resonance imaging.
Using blood samples and other data from patients with mild cognitive impairment from the Alzheimer's Disease Neuroimaging Initiative - a large public-private partnership that began in 2004 - the UCLA researchers found that their method could be used to predict the presence of amyloid in the brain with modest accuracy.
"Our study suggests that blood protein panels can be used to establish the presence of Alzheimer's-type pathology of the brain in a safe and minimally invasive manner," Apostolova said. "We need to further refine and improve on the power of this signature by introducing new disease-related metrics, but this indicates that such a test is feasible and could be on the market before long."
Although there is no treatment that can halt or reverse the progression of Alzheimer's disease, a non-invasive, inexpensive and reliable test for diagnosing the disease could spare people with dementia and their families the anxiety associated with uncertainty, direct them to support services earlier, and improve their likelihood of benefiting from current and future advances in treatment.
Such a test would also have a major impact on research. "With the advent of the amyloid PET scan we are learning that as many as 25-30 percent of subjects who enroll in Alzheimer's disease clinical trials turn out not to have the disease," said Apostolova. "That makes it difficult to measure the effects of the treatment being tested."
INFORMATION:
Other authors of the study include Kristy Hwang, David Avila, Omid Kohannim, David Elashoff and Sophie Sokolow, all of UCLA; Edmond Teng from UCLA and Veterans Affairs Greater Los Angeles Healthcare System; Paul Thompson from the University of Southern California; Clifford Jack from the Mayo Clinic; William Jagust from the UC Berkeley; Leslie Shaw and Dr. John Trojanowski from the University of Pennsylvania School of Medicine; and Dr. Michael Weiner from the University of Pittsburgh and Department of Veterans Affairs Medical Center in San Francisco.
There were multiple funders for the study including the UCLA Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development, the National Institute of Mental Health (U01 AG024904), and the Alzheimer's Disease Neuroimaging Initiative. Please see paper for complete list.
DENVER - Patients treated with definitive concurrent chemotherapy and radiation therapy (CCRT) for stage III non-small cell lung cancer (NSCLC) have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.
Lung cancer is the leading cause of cancer related death in the US with 159,000 deaths and 224,000 diagnoses each year, with NSCLC accounting for 85% of the cases. The stage of lung cancer is determined based on the size of the tumor, the extent and location of lymph node involvement, and whether ...
Birth outcomes for babies whose mothers used assisted reproductive technology (ART) are better in some cases, and worse in others, than for subfertile women who did not use ART, according to a first-of-its-kind study led by Boston University School of Public Health researchers.
Those findings, published online in the journal Fertility and Sterility, suggest that underlying subfertility, distinct from the use of ART, may account for some of the elevated risks in birth outcomes attributed to the use of in vitro fertilization and other ART procedures.
Researchers found ...
This news release is available in German. Time perception is highly subjective and usually depends on the relevant situation so that, for instance, your sense of how fast or slow time is passing can be influenced by whether you are waiting for something or if a deadline is approaching. Patients suffering from depression appear to experience time differently than healthy individuals. Statements made by corresponding patients indicate that for them time seems to pass extremely slowly or even stands still. Psychologists at Johannes Gutenberg University Mainz (JGU) have ...
AMHERST, Mass. - Scientists have long known that leatherback sea turtles travel thousands of miles each year through open ocean to get from foraging habitats to nesting beaches and tropical wintering grounds, but how the wanderers find their way has been "an enduring mystery of animal behavior," says marine biologist Kara Dodge. "Adult turtles can pinpoint specific nesting beaches even after being away many years," she notes.
Sea turtles' ability to identify and maintain appropriate headings affect migration distance, duration and, for reproductively-active adults, breeding ...
Dental diseases, which are caused by the overgrowth of certain bacteria in the mouth, are among the most common health problems in the world. Now scientists have discovered that a material called graphene oxide is effective at eliminating these bacteria, some of which have developed antibiotic resistance. They report the findings in the journal ACS Applied Materials & Interfaces.
Zisheng Tang and colleagues point out that dentists often prescribe traditional antibiotics to get rid of bacteria that cause tooth decay or gum disease. But with the rise in antibiotic resistance, ...
Cigarette use among white teenagers is substantially higher than among black and Hispanic teenagers, especially at 18 years old, according to Penn State researchers.
Alcohol and marijuana use are also higher in white teenagers, and the numbers continue to increase until age 20. Throughout their 20s, blacks and Hispanics are more likely to pick up a cigarette-smoking habit, while the numbers start to decrease for whites.
At 18.5 years old, 44 percent of whites surveyed smoked cigarettes, 27 percent of Hispanics did and 18 percent of blacks. However at 29 years old, ...
HEIDELBERG, 11 March 2015 - Researchers at Harvard Medical School and Columbia University in the United States have developed a way to study the functions of hard-to-grow bacteria that contribute to the composition of the gut microbiome. The new method is published in the journal Molecular Systems Biology.
"Our method, TFUMseq, is a powerful tool for understanding how the wealth of microbes that we harbour in our bodies are so successful at colonizing us. It provides a general high-throughput approach to identify genes that enhance the fitness of microbes over time as ...
Researchers trying to understand wheat-related health problems have found new clues to how the grain's proteins, including gluten, change when cooked and digested. They report in ACS' Journal of Agricultural and Food Chemistry that boiling pasta releases some of its potential allergens, while other proteins persist throughout cooking and digestion. Their findings lend new insights that could ultimately help celiac patients and people allergic to wheat.
Gianfranco Mamone and colleagues point out that pasta is one of the most popular foods in Europe and the U.S. Most people ...
Lithium-ion batteries have enabled many of today's electronics, from portable gadgets to electric cars. But much to the frustration of consumers, none of these batteries last long without a recharge. Now scientists report in the journal ACS Nano the development of a new, "green" way to boost the performance of these batteries -- with a material derived from silk.
Chuanbao Cao and colleagues note that carbon is a key component in commercial Li-ion energy storage devices including batteries and supercapacitors. Most commonly, graphite fills that role, but it has a limited ...
21st March 2015 will see the US launch of the British Psychological Society's Division of Clinical Psychology's ground-breaking report 'Understanding Psychosis and Schizophrenia'.
The report, which will be launched at 9am at the Cooper Union, Manhattan, NYC by invitation of the International Society for Psychological and Social approaches to Psychosis (ISPS), challenges received wisdom about the nature of mental illness and has led to widespread media coverage and debate in the UK.
Many people believe that schizophrenia is a frightening brain disease that makes ...
